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Letter to the Editor
External quality assessment of urinary methylmalonic acid
quantification – results of a pilot study
Table 1 Descriptive statistics for urinary methylmalonic
acid (MMA) results for ten laboratories observed for four
study samples.
Sample MMA, mmol/mol creatinine CV, %
ID
Mean SD Min Max
A 13.0 1.2 9.6 15.5 9.1
B 0.8 0.3 0.5 1.4 44.2
C 5.1 1.1 2.9 6.9 21.0
D 30.0 6.0 19.2 44.7 20.1
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Measurement of methylmalonic acid (MMA) is recog-
nised as a useful tool in the diagnostic work-up of
suspected cobalamin deficiency (1). Increased con-
centrations of MMA in both serum and urine are
indicative of cobalamin deficiency at the tissue level.
MMA measurement in serum as the sample material
is convenient from a logistic point of view, since ana-
lysis can be performed using residual sample material
after serum cobalamin measurement requested as a
screening test. The major drawbacks of serum MMA
measurement, however, are the impact of impaired
renal function leading to high MMA concentrations,
irrespective of individual cobalamin status (2), and the
typically very low concentration range of MMA in
serum samples. In urine, far higher concentrations of
MMA are present compared to serum, facilitating
analyses. Furthermore, calculation of the MMA/crea-
tinine ratio can compensate impaired MMA excretion
in renal failure.
While external quality assessment programs for
serum MMA quantification have been implemented
(3), no corresponding services are available for urin-
ary MMA measurement so far, and no commercial
materials for assay calibration and quality control are
available. In the January 2006 issue of Clinical Chem-
istry and Laboratory Medicine, we announced a pilot
study on external quality assessment of urinary MMA
measurement and invited laboratories to participate
in this investigation. In response to this announce-
ment, a total of ten European laboratories requested
test samples, and lyophilised aliquots of four study
samples were shipped. These samples were manu-
factured (Chromsystems GmbH, Munich, Germany)
by spiking a native urine sample from a healthy vol-
unteer (sample B) with different quantities of a pure
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aqueous solution of methylmalonic acid (Aldrich,
Taufkirchen, Germany; catalogue no. M5,405-8, Lot
32174-494); the calculated increase in MMA concen-
trations in the spiked samples was q3 mg/L (sample
C), q9 mg/L (sample A), and q20 mg/L (sample D).
The creatinine concentration of the samples was
0.57 g/L (Jaffe).
Results expressed as mmol MMA per mol crea-
tinine were reported up to June 2006 by the par-
ticipants (conversion of units: wmmol/mol crea-
tininex=1.04™wmg/g creatininex). Analysis of MMA
was carried out by gas chromatography-mass spec-
trometry in nine laboratories, and by liquid chroma-
tography-tandem mass spectrometry in the remain-
ing laboratory.
Mean creatinine-related urinary MMA concentra-
tions reported for the four study samples are given in
Table 1, together with the respective inter-laboratory
coefficients of variation. All of the results are shown
in Figure 1. The upper limit of the reference range for
urinary MMA reported in different studies varies from
3.5 to 5.1 mg/g creatinine (4–7). The intraindividual
variation of urinary MMA excretion in non-cobalamin-
deficient individuals can be substantial, with coeffi-
cients of variation of approximately 30% (8).
For each result reported by the participants – incor-
porating the inaccuracy of MMA and creatinine quan-
tification – the relative deviation from the mean for
all results reported for each sample was calculated.
This deviation was )20% in 12 of the total 40 meas-
urements (30%). Four laboratories reported results
with less than 20% deviation for all four samples; two
laboratories reported results with less than 20% devi-
ation for three of the four samples. Two further lab-
oratories reported results with less than 20%
deviation for two of the four samples. Among the
results for all samples, three had a deviation of more
than 20% in one laboratory, and in one laboratory the
deviation for all four samples was )20%.
Our data suggest that in a sample of ten European
clinical laboratories, urine with normal MMA concen-
trations (in relation to preliminary reference ranges)
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Figure 1 Individual urinary methylmalonic acid results reported from ten laboratories for four study samples.
Sample A, rhomboids; sample B, squares; sample C, circles; sample D, triangles. Horizontal lines indicate the mean concen-
tration reported for the four samples.
was correctly distinguished from urine with MMA
concentrations typically found in cobalamin deficien-
cy. However, the interlaboratory coefficients of vari-
ation observed in our investigation (approx. 20% at
the decision concentration level) are higher than typ-
ically found in proficiency testing programs for stan-
dard analytes and a deviation of)20% from themean
concentration for samples was observed in a substan-
tial proportion of measurements. Improvement in
interlaboratory agreement of urinary MMA measure-
ment might be achieved if materials for calibration
and routine quality control of urinary MMA measure-
ment become commercially available in the future.
In summary, our study has demonstrated the
necessity of implementing quality assurance systems
for urinary MMA measurement and the feasibility of
an interlaboratory survey using lyophilised samples
for this analyte was demonstrated. Implementation of
a proficiency testing scheme for urinary MMA meas-
urement in the future might be performed in accor-
dance with the Guidelines of the European Co-
operation for Accreditation (EA) (9).
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